Granted Patent B2

US 12,539,358 · App. 16/562,107 · Granted Feb 3, 2026

Inventors: Justin Rice (San Antonio, TX); Christopher Allen Carroll (San Antonio, TX); Shannon C. Ingram (Bulverde, TX); Brett L. Moore (San Antonio, TX)

Assignee: Solventum Intellectual Properties Company

A61M1/92A61B5/0002A61F13/05A61M1/732A61M1/96A61F2013/00174A61F2013/0094A61F13/0253A61M1/772A61M2205/3584

Abstract

Claims (32)

1 . A method for controlling and monitoring a negative-pressure wound treatment device, the method comprising:

transferring an initial therapy configuration from a code that is machine readable to a processor of a therapy device, wherein the therapy device comprises a source of negative pressure, a source of instillation fluid, and a controller including the processor, and wherein the initial therapy configuration includes instillation therapy;

controlling, using the controller, the source of instillation fluid to supply instillation fluid to a dressing based on the initial therapy configuration;

monitoring, at the controller, instillation parameters associated with the supplying of instillation fluid to the dressing to identify instillation alarm conditions;

providing a first corrective action in response to identification of an instillation alarm condition, wherein the first corrective action includes stopping the instillation therapy and starting negative pressure therapy;

controlling, using the controller, the source of negative pressure to apply a first therapeutic negative pressure to a dressing based on the initial therapy configuration;

monitoring, at the controller, negative pressure parameters associated with the application of negative pressure to the dressing to identify negative pressure alarm conditions; and

providing a second corrective action in response to identification of a negative pressure alarm condition, the second corrective action being an adjustment to the source of negative pressure of the negative-pressure wound treatment device made automatically by the controller,

wherein the negative pressure alarm condition is a leak condition and the second corrective action is increasing the negative pressure being applied to the dressing from the first therapeutic negative pressure to a second therapeutic negative pressure.

2 . The method of claim 1 , wherein a further negative pressure alarm condition is a blockage condition and the second corrective action is turning off the application of negative pressure being applied to the dressing.

3 . The method of claim 1 , wherein the instillation alarm condition is a bag empty condition and the first corrective action includes turning off the supply of the instillation fluid being applied to the dressing before starting the negative pressure therapy.

4 . The method of claim 3 , further comprising allowing the instillation fluid to soak the dressing for a dwell time before starting the negative pressure therapy.

5 . The method of claim 1 , wherein the initial therapy configuration comprises therapy settings selected from a group of negative pressure therapy settings including identification of a therapy device, a target pressure, a therapeutic range, a pressure control mode, and a cycle time.

6 . The method of claim 1 , wherein the initial therapy configuration comprises therapy settings selected from a group of instillation therapy settings including identification of an instillation fluid, a fill volume, a dwell time, a fluid pressure, and a negative pressure/instillation ratio.

7 . The method of claim 1 , wherein the initial therapy configuration comprises therapy settings selected from a group of scheduling therapy settings including a daily regimen, a weekday regimen, and a weekend regimen for applying negative pressure and instillation fluid.

8 . The method of claim 1 , wherein the code is adaptable to be modified.

9 . The method of claim 1 , further comprising storing the code on the therapy device.

10 . The method of claim 1 , further comprising printing the code on a label associated with the therapy device or a package associated with disposals used with the therapy device.

11 . The method of claim 1 , wherein transferring the code with the initial therapy configuration to the therapy device is completed from a wireless mobile device.

12 . The method of claim 1 , wherein the code is attached to the therapy device.

13 . The method of claim 1 , wherein the code that is machine readable is a barcode or a QR code and the initial therapy configuration is retrieved from the code by scanning the code with a reader and transferring the initial therapy configuration from the reader to the processor of the therapy device.

14 . The method of claim 1 , further comprising:

modifying, using the controller, the initial therapy configuration to generate a first modified therapy configuration in response to identification of the negative pressure alarm conditions.

15 . The method of claim 14 , wherein providing the second corrective action in response to identification of the negative pressure alarm conditions occurs prior to modifying the initial therapy configuration.

16 . The method of claim 14 , wherein modifying the initial therapy configuration results from an input from a clinician.

17 . The method of claim 14 , wherein modifying the initial therapy configuration results from an alarm condition.

18 . The method of claim 14 , further comprising:

storing the first modified therapy configuration on a first modified code that is machine-readable, the first modified code being a first modified barcode or a first modified QR code.

19 . The method of claim 1 , further comprising:

modifying, using the controller, the initial therapy configuration to generate a second modified therapy configuration in response to identification of the instillation alarm conditions; and

storing the second modified therapy configuration on a second modified code that is machine-readable, the second modified code being a second modified barcode or a second modified QR code.

20 . The method of claim 19 , wherein providing the first corrective action in response to identification of the instillation alarm conditions occurs prior to modifying the initial therapy configuration.

Assignments (4)

Continuity (2)

References Cited (220)